Safety and acceptability of human papillomavirus testing of self-collected specimens: a methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions
A high participation rate is essential for an effective screening programme. A variety of personal and provider level factors influence screening participation [1,2]. One promising approach to reach screening non-responders is to offer them self-collection devices for high-risk human papillomavirus (hrHPV) testing [3 –6].
Source: Journal of Clinical Virology - Category: Virology Authors: Maarit K. Leinonen, Kristina Schee, Christine M. Jonassen, A. Kathrine Lie, Camilla F. Nystrand, Anbj ørg Rangberg, Ingegerd E. Furre, Marzena J. Johansson, Ameli Tropé, Katrine D. Sjøborg, Philip E. Castle, Mari Nygård Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Study | Virology